Clinical trials
Terminated Lymphoma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CRISPR Therapeutics AG | 2 |
| Alpine Immune Sciences, Inc. | 1 |
| Antengene Biologics Limited | 1 |
| Baxalta now part of Shire | 1 |
| Bristol-Myers Squibb | 1 |
| IGM Biosciences, Inc. | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Novartis Pharmaceuticals | 1 |
| Peter MacCallum Cancer Centre, Australia | 1 |
| Rhizen Pharmaceuticals SA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 15 |
| Lymphoma, Non-Hodgkin | 8 |
| Leukemia | 5 |
| Recurrence | 4 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Follicular | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Lymphoma, T-Cell | 3 |
| Lymphoproliferative Disorders | 3 |
| Burkitt Lymphoma | 2 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.